Drugs / CoronaVac-BioFarma
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05226429 Comparator | Feb 2022 → Apr 2023 | COVID-19 | Dr. Soetomo General Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CoronaVac-BioFarma | “Control vaccine in this study is existing CoronaVac-BioFarma inactivated COVID-19 vaccine which has been used widely in Indonesia.” NCT05226429 ↗ |
| Modality | Vaccine | “CoronaVac-BioFarma inactivated COVID-19 vaccine” NCT05226429 ↗ |